InMed Pharmaceuticals (INM) Depreciation Expense: 2022-2025
Historic Depreciation Expense for InMed Pharmaceuticals (INM) over the last 2 years, with Jun 2025 value amounting to $12,206.
- InMed Pharmaceuticals' Depreciation Expense rose 124.37% to $12,206 in Q2 2025 from the same period last year, while for Jun 2025 it was $50,204, marking a year-over-year increase of 5.16%. This contributed to the annual value of $50,204 for FY2025, which is 5.16% up from last year.
- InMed Pharmaceuticals' Depreciation Expense amounted to $12,206 in Q2 2025, which was up 0.02% from $12,203 recorded in Q1 2025.
- InMed Pharmaceuticals' 5-year Depreciation Expense high stood at $14,242 for Q4 2023, and its period low was $5,440 during Q2 2024.
- Its 3-year average for Depreciation Expense is $12,145, with a median of $12,562 in 2023.
- Its Depreciation Expense has fluctuated over the past 5 years, first slumped by 57.88% in 2024, then spiked by 124.37% in 2025.
- Over the past 4 years, InMed Pharmaceuticals' Depreciation Expense (Quarterly) stood at $8,055 in 2022, then soared by 76.81% to $14,242 in 2023, then decreased by 14.27% to $12,209 in 2024, then soared by 124.37% to $12,206 in 2025.
- Its last three reported values are $12,206 in Q2 2025, $12,203 for Q1 2025, and $12,209 during Q4 2024.